Navigation Links
GranuFlo Lawsuits News: Calif. Lawsuit Alleges Drug Maker Hid Serious Health Risks, Rottenstein Law Group LLP Reports
Date:8/30/2013

(PRWEB) August 30, 2013

A group of plaintiffs have filed a GranuFlo lawsuit in California state court, alleging that drug maker Fresenius sold dialysis drug GranuFlo while failing to inform the public of the serious potential risks of use of the drug, including heart attack and stroke, according to court documents. The Rottenstein Law Group LLP, which represents clients in GranuFlo dialysis injury lawsuits, maintains a web page that features information on GranuFlo side effects and lawsuits.

In June 2012 the U.S. Food and Drug Administration issued a Class 1 Recall after learning about the alleged adverse side effects involving the heart.* The FDA had originally approved the drug for distribution in 2003. The plaintiffs argue in the lawsuit that Fresenius warned its doctors at its own dialysis centers about the health risks of GranuFlo, but it did not warn anyone outside the organization (Rodriguez et al. v. Fresenius USA Inc. et al.; BC519374, Los Angeles Superior Court, California). According to court documents, the FDA received a copy of the memo in March 2012 and subsequently took action.

“If these very serious allegations are true, then the courts should hold this company accountable,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. “The plaintiffs—and our own clients on whose behalf we file GranuFlo lawsuits—put their lives in the hands of this company and deserve justice.”

The Rottenstein Law Group LLP encourages those who believe they have suffered from the alleged side effects of GranuFlo to download a free informational brochure about the drug to learn more about its side effects and how to file a lawsuit.

*fda.gov/safety/medwatch/safetyinformation/safetya
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. GranuFlo Lawsuit Consolidation Supported by Fresenius Medical Care, Bernstein Liebhard LLP Reports
2. GranuFlo Recall Website Launched By Hissey Kientz, LLP Law Firm
3. d'Oliveira & Associates Releases Fresenius Infographic about the FDA Recall of NaturaLyte and GranuFlo
4. GranuFlo Lawsuits Filed in Wake of GranuFlo and NaturaLyte Recall Mount in State and Federal Courts, Bernstein Liebhard LLP Reports
5. The National Plaintiff’s Law Firm of Baron and Budd Handling Granuflo Recall Lawsuits
6. New Granuflo Cardiac Arrest Lawsuit: Now, AttorneyOne Can Provide Advice
7. GranuFlo Lawsuit News: Bernstein Liebhard LLP Reports on Growing Litigation Surrounding GranuFlo Recall
8. Fresenius, Maker of Recalled Dialysis Drugs GranuFlo And NaturaLyte, Is Back In The News With Problems At Its Dialysis Center In Bessemer, Alabama
9. GranuFlo Lawsuits Moving Forward in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports
10. GranuFlo Lawsuits Move Forward, as Bernstein Liebhard Notes Issuance of New Order in Federal GranuFlo Recall Litigation
11. GranuFlo Lawsuit News: W.Va. Man’s Lawsuit Goes to Federal Court, Rottenstein Law Group LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... New York (PRWEB) March 30, 2015 ... been filed in California Superior Court on behalf of ... heart birth defect after his mother was prescribed the ... to the March 6th filing in Alameda Superior Court, ... nausea and vomiting that she experienced in the early ...
(Date:3/30/2015)... On March 11, 2015, Elle Magazine, in an article ... new treatment options for dealing with stubborn, unwanted fat. Two ... product. The other three technologies use devices to deliver ultrasound ... cold ( CoolSculpting ) to kill fat cells. (see: goo.gl/NmaB4q) ... to permanently remove unwanted fat," says Dr. Simon Ourian, Medical ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 In a ... March 17th, Governor Chris Christie is championing effective drug ... disorders.New Jersey is scrambling to recover funds to stabilize ... best care for victims of drug and alcohol addiction. ... to those plagued by substance use disorders in New ...
(Date:3/30/2015)... 2015 This report studies the ... the forecast period of 2014 to 2019. This ... of 6.5% from 2014 to 2019. , Further ... report, the global pharmacovigilance and drug safety software ... the basis of functionality, namely, adverse event reporting ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 Dr. Daniel Shapiro, ... , AZ, was recently featured on Phoenix’s Channel 12 News ... procedure is a minimally invasive alternative to facelifts developed by ... and his team at Shapiro Aesthetic Plastic Surgery and Skin ... produce this exclusive news story on GenXLift. The story detailed ...
Breaking Medicine News(10 mins):Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 2Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 4Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 2Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 4Health News:Dr. Daniel Shapiro Unveils New Minimally Invasive Facelift Procedure on Local Newscast 2
... LOS ANGELES, May 22 Generation Rescue, a,non-profit organization ... illness, today announced the expansion of the organization,through three ... Katie Wright have joined the Board,of Directors., Ms. ... recovered her son Evan from autism. Her latest book, ...
... ... difficulties, MINNEAPOLIS, May 22 ... bringing visibility to,dysphagia -- an often undiagnosed, secondary condition resulting from ... makes swallowing extremely difficult and can lead to dangerous,health threats if ...
... Researchers analyze different proteins in progression of risk factors ... -- New insights into lung disease and lung function ... , The researchers analyzed data from the U.S. National ... Development in Young Adults) observational cohort, which recently completed ...
... that in the dog-eat-dog, look-out-for-No. 1, highly competitive business ... to succeed as an entrepreneur. That statement may sound ... A team led by a University of Missouri researcher ... and women decide to pursue entrepreneurship as a viable ...
... International,(Nasdaq: CHDX ) today announced that CEO, ... Ernst & Young Entrepreneur Of The Year(R) 2008 ... & Young LLP, the awards,program recognizes entrepreneurs who ... performance and personal commitment to,their businesses and communities. ...
... JUPITER, Fla., May 22 Atlas Spine, Inc., ... fusion and non-fusion,products, announced today the national launch ... VBR is a radiolucent MIS compatible spacer,system designed ... of,various pathologies of the thoracic and lumbar spine., ...
Cached Medicine News:Health News:Generation Rescue to Target Treatment-Based Research for Autism and ADHD - Jenny McCarthy, Deirdre Imus, and Katie Wright Join Board 2Health News:Generation Rescue to Target Treatment-Based Research for Autism and ADHD - Jenny McCarthy, Deirdre Imus, and Katie Wright Join Board 3Health News:Stroke Victims Often Suffer From Lack of Nutrients With Undiagnosed Disorder 2Health News:Stroke Victims Often Suffer From Lack of Nutrients With Undiagnosed Disorder 3Health News:CARDIA Studies Open Window on Heart, Lung Diseases 2Health News:CARDIA Studies Open Window on Heart, Lung Diseases 3Health News:Taking care of business shouldn't be just for men 2Health News:Chindex International, CEO, Roberta Lipson Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Finalist in Greater Washington 2Health News:Chindex International, CEO, Roberta Lipson Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Finalist in Greater Washington 3Health News:Atlas Spine Launches Stature(TM) Vertebral Body Replacement System 2
(Date:3/30/2015)... 30, 2015 DURECT Corporation (Nasdaq: ... a multi-dose Phase 1 clinical trial of an ... DURECT,s Epigenomic Regulator Program.  DUR-928 is an endogenous, ... broad applicability in metabolic diseases such as nonalcoholic ...  It may also play an important role in ...
(Date:3/30/2015)... , March 30, 2015   GlassesUSA , the ... closing of $12.5 million in new financing led by ... The funding will further GlassesUSA,s aggressive business growth and accelerate ... market of online eyewear, both B2C and B2B. ... , COO Eldad Rothman , and CTO Roy ...
(Date:3/30/2015)... 2015  Zimmer Holdings, Inc. (NYSE and SIX: ... ("EC") has conditionally cleared Zimmer,s proposed acquisition of ... upon Zimmer entering into agreements with a suitable ... package previously submitted to the EC.  Zimmer expects ... term.  As previously announced, the proposed transaction also ...
Breaking Medicine Technology:DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 4GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3Zimmer Announces Clearance by the European Commission of the Pending Biomet Merger 2Zimmer Announces Clearance by the European Commission of the Pending Biomet Merger 3Zimmer Announces Clearance by the European Commission of the Pending Biomet Merger 4Zimmer Announces Clearance by the European Commission of the Pending Biomet Merger 5
Determination of Prothrombin Time (PT)by STA Analyzers (ISI~1.8).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
For the quantitative in vitro determination of Inorganic Phosphorous in serum....
For the quantitative in vitro determination of Magnesium in serum, plasma and urine...
For the quantitative in vitro determination of Lactate Dehydrogenase (LD) in serum and plasma....
Medicine Products: